Leading edge artificial intelligence and machine learning platform supports enhanced salesforce targeting and engagement for cutaneous T-cell lymphoma immunotherapy launch CRANFORD, N.J., Nov. 21, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the...
Hence then, the article about citius oncology to advance commercial launch of lymphir with verix ai integration was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration )
Also on site :
- TIER IV forms capital and business alliance with JR Central to support regional development through rail and autonomous driving integration
- Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure
- CGTN: Why China's anti-corruption drive never stops